Influence of volatile anesthetics on thromboxane A2 signaling

Anesthesiology

Volumn 88, Issue 2, 1998, Pages 440-451

  Hönemann, Christian W ^a,b   Nietgen, Gregor W ^b   Podranski, Tobias ^a   Chan, Carrie K ^b   Durieux, Marcel E ^b  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Allosteric; Competitive; G protein coupled receptor; Halothane; Inhibition; Isoflurane; Sevoflurane; Signaling pathway

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; CALCIUM; CHLORIDE ION; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (2 THIODIPHOSPHATE); HALOTHANE; INHALATION ANESTHETIC AGENT; INOSITOL 1,4,5 TRISPHOSPHATE; ISOFLURANE; MEMBRANE RECEPTOR; MESSENGER RNA; PROSTAGLANDIN; RECEPTOR PROTEIN; SEVOFLURANE; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR;

ANIMAL CELL; ARTICLE; BINDING SITE; CONCENTRATION RESPONSE; CONTROLLED STUDY; FEMALE; MINIMUM LUNG ALVEOLUS CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VOLTAGE CLAMP; XENOPUS;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANESTHETICS, INHALATION; ANIMALS; CHLORIDE CHANNELS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; FEMALE; HALOTHANE; HEPARIN; ISOFLURANE; METHYL ETHERS; OOCYTES; RATS; RECEPTORS, THROMBOXANE; SIGNAL TRANSDUCTION; VASOCONSTRICTOR AGENTS; XENOPUS;

EID: 0345404452     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-199802000-00023     Document Type: Article

References (25)

1. Quinlan JJ, Firestone S, Firestone LL Isoflurane's enhancement of chloride flux through rat brain gamma-aminobutyric acid type A receptors is stereoselective. ANESTIIESIOLOGY 1995; 83:611-5
2. Durieux ME Halothane inhibits signaling through ml muscarinic receptors expressed inXenopns oocytes. ANESTIIESIOLOGY 1995; 82:174-82
3. Chan CK and Durieux ME. Effects of halothane and isoflurane on lysophosphatidate signaling. ANESTHESIOLOGY 1997; 86:660-9
4. Halushka PV, Allan CJ, Davis-Bruno KL Thromboxane A2 receptor. J Lipid Mediat Cell Sign 1995; 12:361-78
5. Biaise GA, Parent M, Laurin S, Omri A, Reader TA, Moutquin JM Platelet-induced vasomotion of isolated canine coronary arter)1 in the presence of halothane or isoflurane. J Cardiothorac Vase Anesth 1994; 8:175-81
6. Hirakata H, Ushikubi F, Toda H, Nakamura K, Sai S, Urabe N, Hatano Y, Narumiya S, Mori K Sevoflurane inhibits human platelet aggregation and thromboxane A2 formation, possibly by suppression of Cyclooxygenase activity. ANESTIIESIOLOGY 1996; 85:1447-53
7. Smaje JC General anesthetics and the acetylcholine sensitivity of cortical neurones. Br J Pharmacol 1976; 58:359-66
8. Durieux ME OoClamp: An IBM-compatible software system for the study of receptors expressed in Xenopns oocytes. Comput Meth Prog Biomed 1993; 41:101-5
9. Lerman J, Gregory GA, Eger EI2 Hematocrit and the solubility of volatile anesthetics in blood. Anesth Analg 1984; 63:911-4
10. Lerman J, Gregor)- GA, Willis MM, Eger El II Age and solubility of volatile anesthetics in blood. ANESTIIESIOLOGY 1984; 61:139-43
11. Franks NP, Lieb WR Selective actions of volatile general anaesthetics at molecular and cellular levels. BrJ Anaesth 1993; 71:65-76
12. Musing RM, Hirata M, Kakizuka A, Eki T, Ozawa K, Narumiya S Characterisation and chromosomal-mapping of the human thromboxane A2 receptor gene. J Biol Chem 1993; 268:25253-9
13. Parys JB, Sernett SW, DeLisle S, Snyder PM, Welsh MJ, Camp-bell KP Isolation, characterization, and localization of the inositol 1,4,5-trisphosphate receptor protein in Xcnopiis laevis oocytes. J Biol Chem 1992; 267:18776-82
14. Stevens WC, Kingston HG Inhalational Anesthesia, Clinical Anesthesia. Edited by PG Barrash, BF Cullen, RK Stocking. Philadelphia, JB Lippincott, 1992, pp 439-65
15. Yamamoto Y, Kamiya K, Teraso S Modeling of human thromboxane A2 receptor and analysis of the receptor-ligand interaction. J Med Chem 1993; 36:820-55
16. Halushka PV, Mais DE Basic and clinical pharmacology of thromboxane A2. Drugs Exp Clin Res 1989; 25:383-93
17. Kurosawa M Role of thromboxane A2 synthetase inhibitors in the treatment of patients with bronchial asthma. Clin Therap 1995; 17:2-11
18. Ogletree ML Overview of physiological and pathophysiological effects of thromboxane A2. Fed Proc 1987; 46:133-88
19. Masterson GR, Hunter JM. Does anaesthesia have a long-term consequences? Br J Anaesth 1996; 77:569-71
20. Hirakata M, Hayashi Y, Ushikubi F, Yokota Y, Kagcyama R, Nakanishi S, Nammiya S Cloning and expression of cDNA for a human thromboxane A2 receptor. Nature 1991; 349:617-20
21. Durieux ME, Nietgen GW Synergistic inhibition of muscarinic signaling by ketamine stereoisomers and the preservative benzethonium chloride. ANESTHESIOLOGY 1997; 86:1326-33
22. Lin LH, Leonard S, Harris A Enflurane inhibits the function of mouse and human brain phosphatidylinositol-linked acetylcholine and serotonin receptors expressed in Xenopus oocytes. Molec Pharmacol 1993; 43:941-8
23. Dilger James P Basic pharmacology of inhalational anesthetic agents, The Pharmacologie Basis of Anesthesiology. Edited by AT Bowdle, A Horita, ED Kharasch. New York, Churchill Livingstone, 1994, pp 497-522
24. Eckenhoff RG An inhalational anesthetic binding domain in the nicotinic acetylcholine receptor. Proc Natl Acad Sei U S A 1996; 93:2807-10
25. Harris BD, Wong G, Moody EJ, Skolnick P Different subunit requirements for volatile and nonvolatile anesthetics at gamma-aminobutyric acid type A receptors. Molec Pharmacol 1995; 47:363-77